1.
Semin Oncol
; 28(6): 593-6, 2001 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-11740815
RESUMO
Three cases of multiple myeloma treated with thalidomide are presented which highlight therapeutic dilemmas presented by therapy with this new agent. The difficulty of stem cell collection during thalidomide therapy is illustrated. The question of continuation of thalidomide after attainment of a plateau or remission is discussed and the management of neuropathy considered. Thalidomide, being a novel drug, presents a number of therapeutic issues that have yet to be resolved.